Rate My Professor Carrie Lucas

Dr. Lucas has garnered significant recognition for her contributions, including the Enders Faculty Fellow award from Yale School of Medicine (2023), Christina Fleischmann Award to Young Women Investigators from the International Cytokine & Interferon Society (2020), CRI CLIP Award from the Cancer Research Institute (2019), Bohmfalk Scholar from Yale School of Medicine (2018), and Charles Hood Foundation Child Health Research Award (2017). Key publications include "Dominant-activating germline mutations in the gene encoding the PI (3) K catalytic subunit p110δ result in T cell senescence and human immunodeficiency" (Nature Immunology, 2014), "Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study" (Journal of Allergy and Clinical Immunology, 2016), "PI3Kδ and primary immunodeficiencies" (Nature Reviews Immunology, 2016), "Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology" (2019), "Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children" (Immunity, 2021), and "PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells" (2024). She serves as Director of Graduate Studies for the Immunobiology program at Yale Graduate School of Arts and Sciences and holds affiliations with the Human and Translational Immunology Program, Yale Center for Genomic Health, Yale Center for Immuno-Oncology, and Yale Center for Systems and Engineering Immunology. Her work has advanced the understanding of primary immunodeficiencies and autoinflammatory diseases.